Service | Details | Compliance | Suppliers |
Select a relevant service
To better assist you with your request, please choose a research area provided by Tianjin Happy Life Tech Co.,Ltd. In case you cannot find an exact match, simply select any service, and our concierge team will swiftly address it once your request has been submitted.
-
Real World Evidence (RWE) Studies
Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
-
Cost Effectiveness Analysis
Compare alternative treatments that lead to similar health outcomes.
-
Decision Analytic Modeling
Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
-
Value Dossiers Development
Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.
-
Comparative Effectiveness
The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
-
Cost Benefit Analysis
Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
-
Patient Treatment Patterns
Assessment of treatment processes and patterns within clinical practice.
-
Clinical Outcomes
Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
-
Health Technology Assessment Submission (HTA Submission)
Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern submissions. See also AMCP and Value Dossier.
-
Formulary & Reimbursement Strategy
Develop strategy and narrative to gain formulary access on insurance plans.
- Load more services